Let Worldwide Guide Your Cystic Fibrosis Clinical Trials
According to the Cystic Fibrosis Foundation, more than 70,000 people worldwide live with cystic fibrosis (CF). Yet, the lives of those burdened by the disease are neither long nor easy. People with CF can live into their 40s and 50s, but the average lifespan is only between 30 and 40 years. And while the gene associated with CF was identified nearly 30 years ago, there are more than 1,700 known mutations of the disease, and a cure has yet to be discovered.
Worldwide Clinical Trials can help you move your CF therapy closer to those who need it most. We have participated in the design, execution, and/or analysis of numerous studies in rare and orphan diseases. We understand the medical, ethical, and operational hindrances that underpin CF trials, and over the course of more than 30 years of conducting clinical trials – in more than 60 countries around the world – we have learned how to anticipate, address, and overcome these issues.
Are you ready to move forward with an experienced, award-winning CRO? Let’s talk.